Risk prediction of death and heart transplantation in adult patients with myocarditis

Anna Baritussio1, Andrea Silvio Giordani1, Chiara Merola1

  • 1Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padua University Hospital and University of Padua, Via Giustiniani 2, Padua 35128, Italy.

Insights

Machine learning identified key predictors of poor outcomes in myocarditis patients. Advanced NYHA class, reduced LVEF, and heart failure indicate a worse prognosis, guiding early intervention for myocarditis.

Area of Science:

  • Cardiology
  • Machine Learning in Medicine
  • Immunology

Background:

  • Myocarditis outcomes vary significantly, necessitating early identification of high-risk patients.
  • Predicting adverse events like death or heart transplant (HTx) is crucial for clinical management.
  • Machine learning (ML) offers a powerful approach to uncover complex predictive patterns in patient data.

Purpose of the Study:

  • To identify early predictors of death and heart transplant (HTx) in adult myocarditis patients.
  • To develop and validate a predictive model using ML techniques.
  • To enhance prognostic accuracy for myocarditis, aiding clinical decision-making.

Main Methods:

  • Retrospective analysis of 938 adult patients with suspected or biopsy-proven myocarditis.
  • Development of a random forest (RF) model to predict death/HTx, ranking variable importance.
  • Collection of clinical, laboratory, and imaging data at diagnosis and during follow-up.

Main Results:

  • The RF model achieved good predictive accuracy (89.2%) for death/HTx.
  • Key predictors identified include NYHA class (10%), LVEF (3.6%), clinical presentation (2.5%), and giant cell myocarditis on EMB (2.9%).
  • Other factors like anti-endothelial cell and anti-nuclear antibodies also showed predictive value.

Conclusions:

  • Advanced NYHA class, reduced LVEF, and heart failure at diagnosis are significant predictors of worse prognosis in myocarditis.
  • Giant cell myocarditis identified on endomyocardial biopsy (EMB) is associated with poorer outcomes.
  • ML models can effectively predict adverse events in myocarditis, supporting risk stratification.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...